Streetbeat News

Analyst Ratings

PEGA

Rosenblatt analyst Blair Abernethy has reiterated a Buy rating for Pegasystems (NASDAQ:PEGA) and maintained a price target of $90.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 1:09 pm

WULF

Rosenblatt analyst Kevin Cassidy has reiterated a Buy rating on TeraWulf (NASDAQ:WULF) and maintained a price target of $5.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 1:07 pm

AMN

MRNA

NKTX

The article highlights three oversold healthcare stocks with potential for recovery: Nkarta Inc (NKTX), Moderna Inc (MRNA), and AMN Healthcare Services (AMN). Nkarta reported strong Q2 results but saw a 35% stock decline. Moderna initiated a Phase 3 trial for a norovirus vaccine, yet its stock fell 23%. AMN Healthcare was downgraded by B of A Securities, leading to a 15% stock drop.

Portfolio Pulse from Avi Kapoor

October 08, 2024 | 1:07 pm

BTDR

Rosenblatt analyst Kevin Cassidy has reiterated a Buy rating for Bitdeer Technologies (NASDAQ:BTDR) and maintained a price target of $9.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 1:05 pm

ABT

BCAX

FXNC

HWM

RCUS

Top Wall Street analysts initiated coverage on several companies with positive ratings. Abbott Laboratories received an Outperform rating with a $130 price target. Arcus Biosciences, Howmet Aerospace, Bicara Therapeutics, and First National Corporation also received positive ratings and price targets.

Portfolio Pulse from Avi Kapoor

October 08, 2024 | 1:03 pm

MTCH

Wells Fargo analyst Ken Gawrelski has maintained an Equal-Weight rating on Match Group (NASDAQ:MTCH) but has lowered the price target from $38 to $35.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 1:03 pm

EXPE

Wells Fargo analyst Ken Gawrelski has maintained an Equal-Weight rating on Expedia Group (NASDAQ:EXPE) while raising the price target from $130 to $159.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 1:01 pm

DY

Dycom Industries (NYSE:DY) has received a range of analyst ratings, with most being bullish. Analysts have raised their price targets, with an average target of $207.8, up from $196.60. The company shows strong financial performance with high revenue growth and profitability, but has a higher debt-to-equity ratio than industry averages.

Portfolio Pulse from Benzinga Insights

October 08, 2024 | 1:00 pm

GRPN

Four analysts have recently assessed Groupon (NASDAQ:GRPN), with ratings ranging from bullish to bearish. The average 12-month price target is $23.5, down from $24.5. Groupon faces financial challenges, including a decline in revenue and profitability metrics below industry averages.

Portfolio Pulse from Benzinga Insights

October 08, 2024 | 1:00 pm

ALB

Albemarle (NYSE:ALB), a major lithium producer, has been analyzed by 16 analysts, showing a range of sentiments from bullish to bearish. Recent analyst actions include several downgrades and lowered price targets, reflecting concerns over Albemarle's financial performance, including a significant revenue decline and below-average profitability metrics. The average 12-month price target has decreased by 21.18%.

Portfolio Pulse from Benzinga Insights

October 08, 2024 | 1:00 pm